QIAGEN: QIAGEN N.V.: QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ende...
Read full article »
QIAGEN is a Germany-based biotechnology company that provides solutions such as molecular diagnostics and sample preparation for pharmaceutical research applications.
Read more